These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17599040)

  • 1. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
    Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
    Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
    Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
    Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1].
    Yue Z; Shen JJ; Huang QT; Qin YF; Li XN; Liu GB
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):675-80. PubMed ID: 27222184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.
    Mozos A; Catasús L; D'Angelo E; Serrano E; Espinosa I; Ferrer I; Pons C; Prat J
    Hum Pathol; 2014 May; 45(5):942-51. PubMed ID: 24746199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
    Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
    Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
    Myatt SS; Wang J; Monteiro LJ; Christian M; Ho KK; Fusi L; Dina RE; Brosens JJ; Ghaem-Maghami S; Lam EW
    Cancer Res; 2010 Jan; 70(1):367-77. PubMed ID: 20028871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
    Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
    Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.
    Devor EJ; Schickling BM; Reyes HD; Warrier A; Lindsay B; Goodheart MJ; Santillan DA; Leslie KK
    Oncol Rep; 2016 Apr; 35(4):2461-5. PubMed ID: 26847831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
    Mylonas I
    Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
    Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
    Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
    Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.
    Berry E; Hardt JL; Clardy J; Lurain JR; Kim JJ
    Gynecol Oncol; 2009 Feb; 112(2):331-6. PubMed ID: 19041124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
    Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J
    Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.
    Zhang J; Jiang Y; Zhao Y; Wang W; Xie Y; Wang H; Yang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317712444. PubMed ID: 28718377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Soufla G; Sifakis S; Spandidos DA
    Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRP78 mediates cell growth and invasiveness in endometrial cancer.
    Calì G; Insabato L; Conza D; Bifulco G; Parrillo L; Mirra P; Fiory F; Miele C; Raciti GA; Di Jeso B; Terrazzano G; Beguinot F; Ulianich L
    J Cell Physiol; 2014 Oct; 229(10):1417-26. PubMed ID: 24526410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
    Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
    Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
    Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
    Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
    Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
    Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.